An investigation into the factors affecting investigator-initiated trial start-up in Ireland
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An investigation into the factors affecting investigator-initiated trial start-up in Ireland ; volume:21 ; number:1 ; day:23 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
Trials ; 21, Heft 1 (23.11.2020), 1-11, 12.2020
- Creator
-
Leddy, Lauren
Sukumar, Prasanth
O’Sullivan, Lydia
Keane, Fionnuala
Devane, Declan
Doran, Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-020-04893-z
- URN
-
urn:nbn:de:101:1-2021010321021863225152
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leddy, Lauren
- Sukumar, Prasanth
- O’Sullivan, Lydia
- Keane, Fionnuala
- Devane, Declan
- Doran, Peter
- SpringerLink (Online service)
Other Objects (12)
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)